,No. of Mths  Year Ending,variable,value,name
0,Net Sales,12  Mar-15*,2606.0,CARE
1,Other income,12  Mar-15*,437.0,CARE
2,Total revenues,12  Mar-15*,3042.0,CARE
3,Gross profit,12  Mar-15*,1596.0,CARE
4,Depreciation,12  Mar-15*,51.0,CARE
5,Interest,12  Mar-15*,13.0,CARE
6,Profit before tax,12  Mar-15*,1969.0,CARE
7,Minority Interest,12  Mar-15*,0.0,CARE
8,Prior Period Items,12  Mar-15*,0.0,CARE
9,Extraordinary Inc (Exp),12  Mar-15*,0.0,CARE
10,Tax,12  Mar-15*,591.0,CARE
11,Profit after tax,12  Mar-15*,1378.0,CARE
12,Gross profit margin,12  Mar-15*,61.2,CARE
13,Effective tax rate,12  Mar-15*,30.0,CARE
14,Net profit margin,12  Mar-15*,52.9,CARE
15,Current assets,12  Mar-15*,1817.0,CARE
16,Current liabilities,12  Mar-15*,783.0,CARE
17,Net working cap to sales,12  Mar-15*,39.7,CARE
18,Current ratio,12  Mar-15*,2.3,CARE
19,Inventory Days,12  Mar-15*,0.0,CARE
20,Debtors Days,12  Mar-15*,22.0,CARE
21,Net fixed assets,12  Mar-15*,567.0,CARE
22,Share capital,12  Mar-15*,290.0,CARE
23,"""Free"" reserves",12  Mar-15*,3232.0,CARE
24,Net worth,12  Mar-15*,3589.0,CARE
25,Long term debt,12  Mar-15*,0.0,CARE
26,Total assets,12  Mar-15*,4455.0,CARE
27,Interest coverage,12  Mar-15*,152.4,CARE
28,Debt to equity ratio,12  Mar-15*,0.0,CARE
29,Sales to assets ratio,12  Mar-15*,0.6,CARE
30,Return on assets,12  Mar-15*,31.2,CARE
31,Return on equity,12  Mar-15*,38.4,CARE
32,Return on capital,12  Mar-15*,55.2,CARE
33,Exports to sales,12  Mar-15*,0.0,CARE
34,Imports to sales,12  Mar-15*,0.0,CARE
35,Exports (fob),12  Mar-15*,0.0,CARE
36,Imports (cif),12  Mar-15*,0.0,CARE
37,Fx inflow,12  Mar-15*,10.0,CARE
38,Fx outflow,12  Mar-15*,8.0,CARE
39,Net fx,12  Mar-15*,2.0,CARE
40,From Operations,12  Mar-15*,1073.0,CARE
41,From Investments,12  Mar-15*,1565.0,CARE
42,From Financial Activity,12  Mar-15*,-2761.0,CARE
43,Net Cashflow,12  Mar-15*,-124.0,CARE
44,Net Sales,12  Mar-16*,2794.0,CARE
45,Other income,12  Mar-16*,87.0,CARE
46,Total revenues,12  Mar-16*,2881.0,CARE
47,Gross profit,12  Mar-16*,1739.0,CARE
48,Depreciation,12  Mar-16*,42.0,CARE
49,Interest,12  Mar-16*,0.0,CARE
50,Profit before tax,12  Mar-16*,1784.0,CARE
51,Minority Interest,12  Mar-16*,0.0,CARE
52,Prior Period Items,12  Mar-16*,0.0,CARE
53,Extraordinary Inc (Exp),12  Mar-16*,0.0,CARE
54,Tax,12  Mar-16*,588.0,CARE
55,Profit after tax,12  Mar-16*,1196.0,CARE
56,Gross profit margin,12  Mar-16*,62.2,CARE
57,Effective tax rate,12  Mar-16*,33.0,CARE
58,Net profit margin,12  Mar-16*,42.8,CARE
59,Current assets,12  Mar-16*,2300,CARE
60,Current liabilities,12  Mar-16*,468,CARE
61,Net working cap to sales,12  Mar-16*,65.6,CARE
62,Current ratio,12  Mar-16*,4.9,CARE
63,Inventory Days,12  Mar-16*,0,CARE
64,Debtors Days,12  Mar-16*,29,CARE
65,Net fixed assets,12  Mar-16*,556,CARE
66,Share capital,12  Mar-16*,294,CARE
67,"""Free"" reserves",12  Mar-16*,3443,CARE
68,Net worth,12  Mar-16*,4087,CARE
69,Long term debt,12  Mar-16*,0,CARE
70,Total assets,12  Mar-16*,5319,CARE
71,Interest coverage,12  Mar-16*,NM,CARE
72,Debt to equity ratio,12  Mar-16*,0,CARE
73,Sales to assets ratio,12  Mar-16*,0.5,CARE
74,Return on assets,12  Mar-16*,22.5,CARE
75,Return on equity,12  Mar-16*,29.3,CARE
76,Return on capital,12  Mar-16*,43.7,CARE
77,Exports to sales,12  Mar-16*,0,CARE
78,Imports to sales,12  Mar-16*,0,CARE
79,Exports (fob),12  Mar-16*,0,CARE
80,Imports (cif),12  Mar-16*,0,CARE
81,Fx inflow,12  Mar-16*,43,CARE
82,Fx outflow,12  Mar-16*,3,CARE
83,Net fx,12  Mar-16*,40,CARE
84,From Operations,12  Mar-16*,1064,CARE
85,From Investments,12  Mar-16*,-409,CARE
86,From Financial Activity,12  Mar-16*,-662,CARE
87,Net Cashflow,12  Mar-16*,-7,CARE
88,Net Sales,12  Mar-17*,2805.0,CARE
89,Other income,12  Mar-17*,341.0,CARE
90,Total revenues,12  Mar-17*,3146.0,CARE
91,Gross profit,12  Mar-17*,1862.0,CARE
92,Depreciation,12  Mar-17*,31.0,CARE
93,Interest,12  Mar-17*,0.0,CARE
94,Profit before tax,12  Mar-17*,2171.0,CARE
95,Minority Interest,12  Mar-17*,0.0,CARE
96,Prior Period Items,12  Mar-17*,0.0,CARE
97,Extraordinary Inc (Exp),12  Mar-17*,0.0,CARE
98,Tax,12  Mar-17*,648.0,CARE
99,Profit after tax,12  Mar-17*,1523.0,CARE
100,Gross profit margin,12  Mar-17*,66.4,CARE
101,Effective tax rate,12  Mar-17*,29.9,CARE
102,Net profit margin,12  Mar-17*,54.3,CARE
103,Current assets,12  Mar-17*,4278,CARE
104,Current liabilities,12  Mar-17*,463,CARE
105,Net working cap to sales,12  Mar-17*,136.0,CARE
106,Current ratio,12  Mar-17*,9.2,CARE
107,Inventory Days,12  Mar-17*,0,CARE
108,Debtors Days,12  Mar-17*,30,CARE
109,Net fixed assets,12  Mar-17*,610,CARE
110,Share capital,12  Mar-17*,295,CARE
111,"""Free"" reserves",12  Mar-17*,4615,CARE
112,Net worth,12  Mar-17*,4953,CARE
113,Long term debt,12  Mar-17*,0,CARE
114,Total assets,12  Mar-17*,5857,CARE
115,Interest coverage,12  Mar-17*,NM,CARE
116,Debt to equity ratio,12  Mar-17*,0,CARE
117,Sales to assets ratio,12  Mar-17*,0.5,CARE
118,Return on assets,12  Mar-17*,26.0,CARE
119,Return on equity,12  Mar-17*,30.7,CARE
120,Return on capital,12  Mar-17*,43.8,CARE
121,Exports to sales,12  Mar-17*,0,CARE
122,Imports to sales,12  Mar-17*,0,CARE
123,Exports (fob),12  Mar-17*,0,CARE
124,Imports (cif),12  Mar-17*,0,CARE
125,Fx inflow,12  Mar-17*,23,CARE
126,Fx outflow,12  Mar-17*,4,CARE
127,Net fx,12  Mar-17*,19,CARE
128,From Operations,12  Mar-17*,1233,CARE
129,From Investments,12  Mar-17*,-276,CARE
130,From Financial Activity,12  Mar-17*,-961,CARE
131,Net Cashflow,12  Mar-17*,-5,CARE
132,Net Sales,12  Mar-18*,3327.0,CARE
133,Other income,12  Mar-18*,255.0,CARE
134,Total revenues,12  Mar-18*,3582.0,CARE
135,Gross profit,12  Mar-18*,2108.0,CARE
136,Depreciation,12  Mar-18*,32.0,CARE
137,Interest,12  Mar-18*,0.0,CARE
138,Profit before tax,12  Mar-18*,2331.0,CARE
139,Minority Interest,12  Mar-18*,0.0,CARE
140,Prior Period Items,12  Mar-18*,0.0,CARE
141,Extraordinary Inc (Exp),12  Mar-18*,0.0,CARE
142,Tax,12  Mar-18*,707.0,CARE
143,Profit after tax,12  Mar-18*,1623.0,CARE
144,Gross profit margin,12  Mar-18*,63.3,CARE
145,Effective tax rate,12  Mar-18*,30.3,CARE
146,Net profit margin,12  Mar-18*,48.8,CARE
147,Current assets,12  Mar-18*,3409,CARE
148,Current liabilities,12  Mar-18*,496,CARE
149,Net working cap to sales,12  Mar-18*,87.6,CARE
150,Current ratio,12  Mar-18*,6.9,CARE
151,Inventory Days,12  Mar-18*,0,CARE
152,Debtors Days,12  Mar-18*,43,CARE
153,Net fixed assets,12  Mar-18*,602,CARE
154,Share capital,12  Mar-18*,295,CARE
155,"""Free"" reserves",12  Mar-18*,5674,CARE
156,Net worth,12  Mar-18*,5968,CARE
157,Long term debt,12  Mar-18*,0,CARE
158,Total assets,12  Mar-18*,6586,CARE
159,Interest coverage,12  Mar-18*,NM,CARE
160,Debt to equity ratio,12  Mar-18*,0,CARE
161,Sales to assets ratio,12  Mar-18*,0.5,CARE
162,Return on assets,12  Mar-18*,24.6,CARE
163,Return on equity,12  Mar-18*,27.2,CARE
164,Return on capital,12  Mar-18*,39.1,CARE
165,Exports to sales,12  Mar-18*,0,CARE
166,Imports to sales,12  Mar-18*,0,CARE
167,Exports (fob),12  Mar-18*,0,CARE
168,Imports (cif),12  Mar-18*,0,CARE
169,Fx inflow,12  Mar-18*,24,CARE
170,Fx outflow,12  Mar-18*,2,CARE
171,Net fx,12  Mar-18*,22,CARE
172,From Operations,12  Mar-18*,1338,CARE
173,From Investments,12  Mar-18*,-246,CARE
174,From Financial Activity,12  Mar-18*,-987,CARE
175,Net Cashflow,12  Mar-18*,105,CARE
176,Net Sales,12  Mar-19*,3190.0,CARE
177,Other income,12  Mar-19*,304.0,CARE
178,Total revenues,12  Mar-19*,3494.0,CARE
179,Gross profit,12  Mar-19*,1747.0,CARE
180,Depreciation,12  Mar-19*,33.0,CARE
181,Interest,12  Mar-19*,0.0,CARE
182,Profit before tax,12  Mar-19*,2017.0,CARE
183,Minority Interest,12  Mar-19*,0.0,CARE
184,Prior Period Items,12  Mar-19*,0.0,CARE
185,Extraordinary Inc (Exp),12  Mar-19*,0.0,CARE
186,Tax,12  Mar-19*,637.0,CARE
187,Profit after tax,12  Mar-19*,1381.0,CARE
188,Gross profit margin,12  Mar-19*,54.8,CARE
189,Effective tax rate,12  Mar-19*,31.6,CARE
190,Net profit margin,12  Mar-19*,43.3,CARE
191,Current assets,12  Mar-19*,2794,CARE
192,Current liabilities,12  Mar-19*,489,CARE
193,Net working cap to sales,12  Mar-19*,72.2,CARE
194,Current ratio,12  Mar-19*,5.7,CARE
195,Inventory Days,12  Mar-19*,0,CARE
196,Debtors Days,12  Mar-19*,54,CARE
197,Net fixed assets,12  Mar-19*,831,CARE
198,Share capital,12  Mar-19*,295,CARE
199,"""Free"" reserves",12  Mar-19*,5205,CARE
200,Net worth,12  Mar-19*,5500,CARE
201,Long term debt,12  Mar-19*,0,CARE
202,Total assets,12  Mar-19*,6151,CARE
203,Interest coverage,12  Mar-19*,NM,CARE
204,Debt to equity ratio,12  Mar-19*,0,CARE
205,Sales to assets ratio,12  Mar-19*,0.5,CARE
206,Return on assets,12  Mar-19*,22.4,CARE
207,Return on equity,12  Mar-19*,25.1,CARE
208,Return on capital,12  Mar-19*,36.7,CARE
209,Exports to sales,12  Mar-19*,0,CARE
210,Imports to sales,12  Mar-19*,0,CARE
211,Exports (fob),12  Mar-19*,0,CARE
212,Imports (cif),12  Mar-19*,0,CARE
213,Fx inflow,12  Mar-19*,25,CARE
214,Fx outflow,12  Mar-19*,3,CARE
215,Net fx,12  Mar-19*,22,CARE
216,From Operations,12  Mar-19*,1086,CARE
217,From Investments,12  Mar-19*,826,CARE
218,From Financial Activity,12  Mar-19*,-1954,CARE
219,Net Cashflow,12  Mar-19*,-42,CARE
